top of page

Leveraging enzymes to help scale RNA therapies and other biocatalyst use cases with the CEO of Codexis

Stephen Dilly describes how Codexis is trying help RNA companies use enzymes to more efficiently make oligonucleotides, and also as a biocatalyst for other RNA and DNA based products. Afterwards, we take a tour of the company's labs.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page